These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 32982969)

  • 1. Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.
    Wang M; Tan Y; Shi Y; Wang X; Liao Z; Wei P
    Front Endocrinol (Lausanne); 2020; 11():568. PubMed ID: 32982969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.
    Hong SH; Choi KM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenic obesity.
    Polyzos SA; Margioris AN
    Hormones (Athens); 2018 Sep; 17(3):321-331. PubMed ID: 30014320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.
    Cleasby ME; Jamieson PM; Atherton PJ
    J Endocrinol; 2016 May; 229(2):R67-81. PubMed ID: 26931135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenic Obesity and Amino Acids: Concord Health and Ageing in Men Project.
    Le Couteur DG; Handelsman DJ; Stanaway F; Waite LM; Blyth FM; Naganathan V; Cumming RG; Hirani V
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1000-1004. PubMed ID: 33709116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT-time-to-glucose-peak.
    Kim JY; Tfayli H; Bacha F; Lee S; Michaliszyn SF; Yousuf S; Gebara N; Arslanian S
    Pediatr Diabetes; 2020 Feb; 21(1):18-27. PubMed ID: 31677208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
    Consitt LA; Clark BC
    J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships between sarcopenic skeletal muscle loss during ageing and macronutrient metabolism, obesity and onset of diabetes.
    Welch AA; Hayhoe RPG; Cameron D
    Proc Nutr Soc; 2020 Feb; 79(1):158-169. PubMed ID: 31685055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project.
    Scott D; Cumming R; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Seibel M; Waite LM; Hirani V
    Exp Gerontol; 2018 Jul; 108():99-105. PubMed ID: 29649572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daniel Porte Jr.: A Leader in Our Understanding of the Role of Defective Insulin Secretion and Action in Obesity and Type 2 Diabetes.
    Palmer JP; Kahn SE; Schwartz MW; Taborsky GJ; Woods SC
    Diabetes Care; 2020 Apr; 43(4):704-709. PubMed ID: 32198285
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study.
    Kim TN; Park MS; Lim KI; Choi HY; Yang SJ; Yoo HJ; Kang HJ; Song W; Choi H; Baik SH; Choi DS; Choi KM
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):525-32. PubMed ID: 22563924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention.
    Li CW; Yu K; Shyh-Chang N; Li GX; Jiang LJ; Yu SL; Xu LY; Liu RJ; Guo ZJ; Xie HY; Li RR; Ying J; Li K; Li DJ
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):586-600. PubMed ID: 30969486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aging and insulin resistant states on protein anabolic responses in older adults.
    Morais JA; Jacob KW; Chevalier S
    Exp Gerontol; 2018 Jul; 108():262-268. PubMed ID: 29723655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
    McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
    BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.